首页> 美国卫生研究院文献>BMC Public Health >Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)

【2h】

Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)

机译：瑞典血脂异常患者（PRIMULA）进行脂质修饰治疗前后脂质异常的发生率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundData on the prevalence of dyslipidemia and attainment of goalormal lipid levels in a Swedish population are scarce. The objective of this study is to estimate the prevalence of dyslipidemia and attainment of goalormal lipid levels in patients treated with lipid modifying therapy (LMT).

机译：背景技术关于瑞典人群血脂异常患病率和达到目标/正常血脂水平的数据很少。这项研究的目的是评估接受脂质修饰疗法（LMT）治疗的患者的血脂异常患病率和达到目标/正常脂质水平。

著录项

期刊名称 BMC Public Health
作者
Billie Pettersson; Baishali Ambegaonkar; Vasilisa Sazonov; Mats Martinell; Jan Stålhammar; Per Wändell;
展开▼
作者单位

展开▼
年(卷),期 2010(10),-1
年度 2010
页码 737
总页数 10
原文格式 PDF
正文语种
中图分类公共卫生工程;
关键词

相似文献

外文文献
中文文献
专利

1. Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA) [J] . Billie Pettersson, Baishali Ambegaonkar, Vasilisa Sazonov, BMC Public Health . 2010,第1期

机译：瑞典血脂异常患者（PRIMULA）进行脂质修饰治疗前后脂质异常的发生率
2. The DYSlipidemia International Study (DYSIS)-Egypt: A report on the prevalence of lipid abnormalities in Egyptian patients on chronic statin treatment [J] . Adel El Etriby, Peter Bramlage, Amany El Nashar, The Egyptian Heart Journal . 2013,第3期

机译：埃及血脂异常国际研究（DYSIS）：埃及他汀类药物长期治疗的脂质异常患病率报告
3. Persistent lipid abnormalities in patients with hypertension and dyslipidemia treated with statins: results of the Portuguese hypertensive subpopulation of the Dyslipidemia International Study (DYSIS) [J] . Silva Pedro M., Cardoso Salvador M., Ferreira Antonio M. Clinical and experimental hypertension: CEH . 2015,第2期

机译：他汀类药物治疗的高血压和血脂异常患者的持续脂质异常：国际血脂异常研究（DYSIS）的葡萄牙高血压亚群的结果
4. Effect of highly active antiretroviral therapy (HAART) on lipid abnormalities in HIV-infected patients [C] . Estari Mamidala 2011 international conference on medical information and bioengineering. . 2011

机译：高效抗逆转录病毒疗法（HAART）对HIV感染患者血脂异常的影响
5. Dyslipidemia among HIV-infected tuberculosis patients taking once-daily non-nucleoside reverse transcriptase inhibitor based antiretroviral therapy in India. [D] . Chandrasekaran, Padmapriyadarsini. 2010

机译：在印度，每天接受一次基于非核苷类逆转录酶抑制剂的抗逆转录病毒疗法的HIV感染结核病患者的血脂异常。
6. Prevalence of mixed dyslipidemia among Australian patients undergoing lipid-modifying therapy [O] . David Colquhoun, Diana Chirovsky, Valsilisa Sazonov, 2013

机译：接受脂质改良治疗的澳大利亚患者混合血脂异常的患病率
7. Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA) [O] . Billie Pettersson, Baishali Ambegaonkar, Vasilisa Sazonov, 2011

机译：瑞典血脂异常患者（PRIMULA）进行脂质修饰治疗前后脂质异常的发生率

Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)

摘要

著录项

相似文献

相关主题

期刊订阅